article thumbnail

Over-the-Counter Choices Pharmacist Role and Resources

FADIC

This requires staying updated on the latest information through continuing education and communicating with other healthcare professionals. Pharmacists should also inquire about any allergies or sensitivities the patient may have to ensure they are not recommending an OTC medication that could cause an adverse reaction.

article thumbnail

Unlocking the potential in rare disease research with decentralised trials

pharmaphorum

When asked about features of decentralised trial designs that people found most attractive, the top reasons given were the convenience of having more of the study take place at home and less time traveling, as well as the use of technology, both to communicate with research staff and to have their health monitored.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Herd immunity is nice – but what about me?

pharmaphorum

But, here again, we’re seeing a situation in which the need for consistent communication around public health goals is overshadowing the very real need to know our own, personal exposure risk levels. For that reason, the FDA is right to caution the public against an over-reliance on simple, negative/positive antibody tests.

Immunity 105
article thumbnail

UCPMP 2024 Quiz

PharmaState Academy

5 / 15 In what manner should adverse drug reactions be disclosed in promotional materials to comply with UCPMP 2024? 6 / 15 Under what circumstances can a pharmaceutical company provide financial support to a healthcare professional attending an international conference?

article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

FDA Law Blog: Biosimilars

As another example, both documents note the possibility that if FDA has safety information relevant to an ongoing study, it may request that the sponsor confirm that the DMC is aware of that safety data and is taking it into consideration, or “request that the sponsor arrange for FDA to communicate with, or even meet with, the DMC.”

article thumbnail

How Long Until AI Starts to Replace Pharmacists

pharmacy mentor

AI algorithms can analyse patient data to predict potential drug interactions, customise treatment plans, and even identify early signs of adverse reactions. By leveraging AI, pharmacies can already optimise drug dispensing processes, improve medication management, and enhance patient safety.

article thumbnail

Medicines adherence: Overcoming pharma’s biggest barrier to treatment success

Pharmaceutical Technology

Following on from these observations, companion apps (running on smartphones) and digital adherence technologies (DATs) can provide valuable assistance to improve some of these aspects, such as doctor/patient communications, education, medication tracking, encouragement, and reminders.